1:18
Mesenchymal Stem Cells in Cancer Immunotherapy: Promises and Challenges | Oncotarget
Oncotarget
2:02
Tumor Dormancy Initiated by Lymphovascular Embolus | Oncotarget
1:30
Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition | Oncotarget
1:57
UBA1 Dysfunction in VEXAS and Cancer | Oncotarget
1:34
Targeting CD47/SIRPĪ± 'Do Not Eat Me' Axis: Advances and Challenges in Cancer Therapy | Oncotarget
1:06
Generative AI in Cancer Imaging: Revolutionizing Detection & Diagnosis | Oncotarget
1:46
Case for Inflammatory Memory for Hematopoietic Stem and Progenitor Cells in AML Niche | Oncotarget
1:05
Targeting WNT5B and WNT10B in Osteosarcoma | Oncotarget
1:14
Artificial Intelligence: Revolutionizing Precision Oncology | Oncotarget
1:27
Genotype Matters: Tailored Screening for Germline CHEK2 Variants | Oncotarget
1:39
Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity | Oncotarget
2:42
Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors | Oncotarget
0:58
How to Deal with Runaway Metastatic Disease? | Oncotarget
2:39
Enhanced Pembrolizumab Efficacy with EphB4-Albumin in HPV-Negative Head and Neck Cancer | Oncotarget
1:28
DDX41 and its Unique Contribution to Myeloid Leukemogenesis | Oncotarget
2:44
FDG-PET/CT vs. CT for Tumor Response to Nivolumab Plus Ipilimumab in Mesothelioma | Oncotarget
2:16
GZ17-6.02 Kills PDX Isolates of Uveal Melanoma | Oncotarget
2:10
Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget
Cyclin D1 Expression in Penile Cancer | Oncotarget
Bispecific Antibodies for B-cell Lymphoma Treatment | Oncotarget
Role of GHRH Antagonist MIA-602 in AML Treatment | Oncotarget
2:03
ABT199/Venetoclax Synergism with Thiotepa Enhances AML Cytotoxicity | Oncotarget
Validation of NeXT PersonalĀ®: Ultra-Sensitive ctDNA Assay | Oncotarget
2:20
GZ17-6.02 Interacts with Proteasome Inhibitors to Kill Multiple Myeloma Cells | Oncotarget
2:21
Germline BRCA1 and BRCA2 in Ovarian Cancer Patients: Salento Study | Oncotarget
2:06
GZ17-6.02 Interacts with Bexarotene to Kill Mycosis Fungoides Cells | Oncotarget
2:15
Mad2 Gene Expression & Histone Modifications in Esophageal Cancer | Oncotarget
2:09
Thyroid Cancer Genetic Alterations: BRAF Resistance and Anaplastic Transformation | Oncotarget
2:17
Bone Marrow Adipocytes Provide Early Sign for Progression from MGUS to Multiple Myeloma | Oncotarget
1:47
Therapeutically Harnessing Cancer Stem Cell-Derived Exosomes | Oncotarget
GFH009: CDK9 Inhibitor for Hematologic Malignancies | Oncotarget
Melatonin and Carcinogenesis in Mice: 50th Anniversary of Relationships | Oncotarget
Osteopontin Induces Mitochondrial Biogenesis in Cancer Cells | Oncotarget
C/EBPĪ² Cooperates with MYB to Maintain Oncogenic Program of AML Cells | Oncotarget
1:35
SHP2 Tyrosine Phosphorylation and Allosteric Inhibitor Resistance | Oncotarget
p53's Protective Role Against Biliary Precancerous Lesions with Oncogenic Kras | Oncotarget
1:58
Neutrophil PAD4: How Does it Function in Cancer Beyond Promoting NETosis? | Oncotarget
UDP-Glucose Dehydrogenase (UGDH) in Clinical Oncology and Cancer Biology | Oncotarget
DISE: Ancient Anti-Cancer Mechanism Sensing Mutational Load in Cancerous Cells? | Oncotarget
1:45
Reassessing the Risks and Benefits of COVID-19 Precautions in 2023 | Oncotarget
2:01
Novel Receptors Linking Endometrial Cancer & PCOS: Transcriptomic Insights | Oncotarget
1:31
The Hope for Targeting Fatty Acid Binding Proteins in Multiple Myeloma | Oncotarget
1:59
Predicting Molecular Functions of Regulatory Genetic Variants Associated with Cancer | Oncotarget
1:10
Adopted Neoplastic Cells and Consequences of Their Existence | Oncotarget
1:33
A Macrophage is a Macrophage is a Macrophageāin Metastasis | Oncotarget
Inhibition of Glutamine Metabolism: Acting on Tumoral Cells or Tumor Microenvironment? | Oncotarget
1:19
A Balancing Act: How Whole-genome Doubling and Aneuploidy Interact in Human Cancer | Oncotarget
CDK9 Inhibitors: Promising Combination Partner for Hematological Malignancy Treatment | Oncotarget
1:54
AGO2 in T-Prolymphocytic Leukemia: Deregulation and Function | Oncotarget
Turning Immunosuppressive Tumors to Immunostimulatory: Nerofe and Doxorubicin's Impact | Oncotarget
2:00
Dark Side of PLK1: Implications for Cancer and Genomic Instability | Oncotarget
1:15
Decoding the Mechanism Behind MCL-1 Inhibitors | Oncotarget
1:24
Targeting GITR in Cancer Immunotherapy ā There Is No Perfect Knowledge | Oncotarget
2:11
Genetic Investigation: Pathogenic Variants in Saudi Patients With Familial Cancer | Oncotarget
Role of Creatine Shuttle in Colorectal Cancer Cells | Oncotarget
1:52
Automated, Accurate Reporting for NGS-Based Clonality Testing | Oncotarget
1:53
Human LY6 Gene Family: Biomarkers for Uterine Endometrial Cancer Prognosis | Oncotarget
Systemic AL Amyloidosis: Current Approach and Future Direction | Oncotarget
2:25
Importance of Carbohydrate Antigen (CA 19-9) and Carcinoembrionic Antigen (CEA) | Oncotarget
Cancer-Associated Fibroblasts: Challenges and Opportunities | Oncotarget
1:25
Proof-of-Principle: Targeted Childhood Leukemia Prevention | Oncotarget
1:56
What is Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score? | Oncotarget
1:49
Oncogenic Driver FGFR3-TACC3 Requires Five Coiled-Coil Heptads | Oncotarget
2:04
Why is it Difficult to Control Glycolytic Flux by Blocking Lactate Transporters? | Oncotarget
Gastric Cancer Survival Outcome Prediction With Novel Inflammation Index | Oncotarget
Impact of Covid-19 on Management of Patients With Metastatic Melanoma | Oncotarget
1:51
p-STAT3 & c-Myc Correlate With P2-HNF4Ī± Expression in Nonalcoholic Fatty Liver Disease | Oncotarget
Treasures From Trash in Cancer Research | Oncotarget
Genomic Alterations Predictive of Poor Clinical Outcomes in Pan-cancer | Oncotarget
Influence of High Altitude on Ecuadorian Patients with Gastric Adenocarcinoma | Oncotarget
1:38
Glycosylation of Metastasis-associated Glycoproteins Defines Invasive Cancer Phenotype | Oncotarget
A Novel Regulatory Mechanism of GLI3 by Toll-like Receptor Signaling | Oncotarget
1:23
Grb2 and PLCĪ³1 Required in BCR-FGFR1-Driven SCLL | Oncotarget
0:59
Variants and Polymorphisms in Bladder Cancer | Oncotarget
10:39
Mitigating Radiation for Space Colonization | Oncotarget
0:56
Oncotarget | Adaptor Protein Regulates Donor T Cell Migration
0:55
Oncotarget | Genomic and Neoantigen Evolution in Head, Neck Cancer
Oncotarget | Negative Effects of the Spike Protein in SARS-CoV-2 and Some Vaccines
0:48
Oncotarget | The Cholera Toxin and Inflammation-associated Obesity
0:52
Oncotarget | A Study on Biomarkers of Endometrial Cancer Progression
8:39
Oncotarget | CrkL Required for Donor T Cell Migration to GvHD Target Organs
25:42
Oncotarget | Zebrafish B Cell Acute Lymphoblastic Leukemia: New Findings in Old Model
11:26
Oncotarget | Functional Inhibitor Compounds Inhibit Herpes Simplex Virus Proliferation
11:42
Oncotarget | Reversing Oncogenic Transformation With Iron Chelation
6:49
Oncotarget | Unique Biomarker Analysis & Interpretation Platform in Clinical Decision-making
5:09
Oncotarget | GATA3 and APOBEC3B are Prognostic Markers in Adrenocortical Carcinoma
15:51
Oncotarget | Consuming Cholera Toxin Counteracts Age-associated Obesity
9:23
Oncotarget | Genomic and Neoantigen Evolution in Head and Neck Squamous Cell Carcinoma
0:54
Oncotarget: Hedgehog Signaling Induces Proliferation in Gastric Cancer
Oncotarget: CRISPR/Cas9 Reveals Diverse Transcriptional Regulation and Functional Effects
0:46
Oncotarget: Smurf2 Regulation of HIF-1Ī± in Cancer Cells
19:30
Oncotarget: Epigenetic feedback and stochastic partitioning can drive resistance to EMT
0:53
Oncotarget: Nanoparticles Target Acute Myeloid Leukemia
Oncotarget: EMTs Produce Endothelial Cells & Tumor Growth
Oncotarget: Tumors, Cortisol, Relacorilant, and Cytotoxic Agents
16:06
Oncotarget: Epithelial-mesenchymal transitions create endothelial cells & tumor growth
0:51
Oncotarget: Exercise Enhances Doxorubicinās Antitumor Effects
0:57
Oncotarget: T-Cell-Targeted Immunotherapy for Recurrent HNSCC
Oncotarget: Metal Compounds Induce DNA Instability in Cancer Cells
0:47
Oncotarget: New HPV Assay to Predict HNSCC Treatment Response
0:49
Oncotarget: Esomeprazole and Tumor Control
Oncotarget Trending Effects of Retinoic Acid in Non APL AML cells
Oncotarget: Novel Urine Protein Biomarkers in Bladder Cancer
Oncotarget: Role of the MYCN Oncogene in Neuroblastoma
1:00
Oncotarget: Blood-Based Biomarker in SCCA
Oncotarget: Evaluating the Role of IGF/CTP Composite Score in Sorafenib Treatment
LIVE
[Private video]
Oncotarget: Novel Phospho-site in EMSY-driven Suppression of DNA Damage Repair
Oncotarget: A New Potential Network of Biomarkers Useful Across Sarcomas
Oncotarget: The Vitamin D Binding Protein in Thyroid Cancer
Oncotarget | Neoantigen Evolution in Head and Neck Tumors
0:42
Oncotarget: Hepatocellular Carcinoma in The Andes Mountains
3:41
Dr. David Loeb, Pediatric Oncologist Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
6:08
Down Syndrome iPSC Model: Endothelial Perspective on Tumor Development | Oncotarget
4:13
Oncotarget: BHD Symposium & International Upstate Kidney Cancer Symposium
7:54
Oncotarget: Transcription and proliferation of human tumor cells
2:50
Oncotarget: Llgl1 prevents metaplastic survival
7:24
Oncotarget: p53 knockdown to promote malignant peripheral nerve sheath tumor formation
5:35
Oncotarget: PRAME associated with increased metastatic risk
7:35
Oncotarget: Therapeutic strategy for drug-resistant thyroid cancers
4:09
Oncotarget: Addiction to Runx1 is partially attenuated by loss of p53
7:58
Oncotarget: Inhibit oral squamous carcinoma cell migration and viability
Oncotarget: Molecular trigger for invasiveness in prostate cancer cells
10:00
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
4:45
Oncotarget: Dendritic cell sarcoma & rapid research autopsy
11:17
Oncotarget: Metronomic cyclophosphamide - innate immunity and anti-tumor responses
